Cytomegalovirus DNA Presence in Southern Chinese Patients with Anti-Melanoma Differentiation-Associated Gene 5 Positive Dermatomyositis - Scorecard - MDSpire

Cytomegalovirus DNA Presence in Southern Chinese Patients with Anti-Melanoma Differentiation-Associated Gene 5 Positive Dermatomyositis

  • By

  • Yuanyuan Niu

  • Huijuan Hu

  • Yuting Gu

  • Kai Sun

  • Qian Qiu

  • Di Fu

  • Haonan Chen

  • Liuqin Liang

  • Shanhui Ye

  • Youjun Xiao

  • Hanshi Xu

  • February 9, 2026

  • 0 min

Share

Clinical Scorecard: Cytomegalovirus DNA Presence in Southern Chinese Patients with Anti-Melanoma Differentiation-Associated Gene 5 Positive Dermatomyositis

At a Glance

CategoryDetail
Condition
Key MechanismsRevise to include clinical implications of CMV DNAemia.
Target Population
Care Setting

Key Highlights

  • highlight_1

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • A
      • d
      • d
      • d
      • e
      • t
      • a
      • i
      • l
      • s
      • o
      • n
      • t
      • h
      • e
      • c
      • l
      • i
      • n
      • i
      • c
      • a
      • l
      • s
      • i
      • g
      • n
      • i
      • f
      • i
      • c
      • a
      • n
      • c
      • e
      • o
      • f
      • C
      • M
      • V
      • D
      • N
      • A
      • l
      • e
      • v
      • e
      • l
      • a
      • s
      • s
      • e
      • s
      • s
      • m
      • e
      • n
      • t
      • s
      • .

      Risks

        Patient & Prescribing Data

        Provide more context on how multi-target immunotherapy increases CMV risk.

        Clinical Best Practices

        • best_practice_2

        References

        Original Source(s)

        Cytomegalovirus DNA Presence in Southern Chinese Patients with Anti-Melanoma Differentiation-Associated Gene 5 Positive Dermatomyositis

        • by Yuanyuan Niu, Huijuan Hu, Yuting Gu, Kai Sun, Qian Qiu, Di Fu, Haonan Chen, Liuqin Liang, Shanhui Ye, Youjun Xiao, Hanshi Xu

        • February 9, 2026

        Related Content

        Botulinum Toxin Evaluated in Digital Ischemia

        Individual-level meta-analysis examines response, dosing, and safety across ischemic etiologies

        The Loan Cap That Could Shrink the Doctor Pipeline

        New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

        Who Decides When a Doctor Steps Back?

        Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.